2. Although the quest for a safe and effective vaccine remains unsuccessful, the more
vulnerable patients can be protected with passive prophylaxis. Because of limited clinical …

Respiratory syncytial virus (RSV) is the most common respiratory pathogen in infants and
young children worldwide. More than 50 years after its discovery, and despite relentless …

Respiratory syncytial virus (RSV) infects all children early in life, is the most common cause
of infant lower respiratory tract infections, and causes disease exacerbations in children with …

Bronchiolitis is a common lower respiratory tract infection in infants and young children, and
respiratory syncytial virus (RSV) is the most common cause of this infection. RSV is …

Respiratory syncytial virus (RSV) infection is ubiquitous with almost all infants having been
infected by 2 years of age and lifelong repeated infections common. It is the second largest …

Evidence from a large number of prospective case-control studies shows that respiratory
syncytial virus (RSV) bronchiolitis in infancy is often associated with recurrent wheezing and …

Asthma risk is lower after wheezing associated with respiratory syncytial virus (RSV) than
with non-RSV infection in infancy. RSV is the main wheezing-associated virus in infants …

Respiratory syncytial virus is a medium-sized (120 to 300 nm) enveloped ribonucteic acid
virus of the paramyxovirus family that is a ubiquitous pathogen in all age groups. l Two …

One of the major questions regarding long‐term side effects of bronchiolitis by respiratory
syncytial virus (RSV) is whether or not it induces asthma in later life. In this quantitative …

On this felicitous occasion we honor Dr Saul Krugman for his many contributions to the study
and control of a wide variety of important pediatric viral diseases. In preparing our remarks …